1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 146 Hits
  • Search Condition : Filter (MeSH = Drug Synergism)
Species Resource
Pathogenic microorganisms IFM 41621 , IFM 41624 Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
Pathogenic microorganisms IFM 0187 , IFM 0236 , IFM 0237 , IFM 0239 , IFM 0262 , IFM 0280 , IFM 0283 , IFM 0284 , IFM 0290 , IFM 0319 , ... Nocardia cyriacigeorgica is a significant pathogen responsible for nocardiosis in Japan and Thailand.
Human and Animal Cells PC-12 Smad mediates BMP-2-induced upregulation of FGF-evoked PC12 cell differentiation.
Human and Animal Cells K562 Depsipeptide enhances imatinib mesylate-induced apoptosis of Bcr-Abl-positive cells and ectopic expression of cyclin D1, c-Myc or active MEK abrogates this effect.
Human and Animal Cells NB1RGB Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma.
Human and Animal Cells RAW 264 Interleukin-15 induces IL-12 receptor beta1 gene expression through PU.1 and IRF 3 by targeting chromatin remodeling.
Mice B6.Cg-Tg(CAG-Cre)CZ-MO2Osb(RBRC01828) New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome.
Pathogenic microorganisms IFM 40147 Synergistic postantifungal effect of flucytosine and fluconazole on Candida albicans.
Mice IRF-7 knockout mice , C57BL/6J(RBRC01420) TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN.
Pathogenic microorganisms IFM 41624 Effect of cytokines on antifungal activity of human polymorphonuclear leucocytes against yeast cells of Paracoccidioides brasiliensis.
Human and Animal Cells Synergism of α-linolenic acid, conjugated linoleic acid and calcium in decreasing adipocyte and increasing osteoblast cell growth.
Human and Animal Cells Utilization of 6-(methylsulfinyl)hexyl isothiocyanate for sensitization of tumor cells to antitumor agents in combination therapies.
Human and Animal Cells Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non-small-cell lung cancer.
Human and Animal Cells Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.
Human and Animal Cells Phosphodiesterase 5 inhibitor acts as a potent agent sensitizing acute myeloid leukemia cells to 67-kDa laminin receptor-dependent apoptosis.
Human and Animal Cells Synergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.
Human and Animal Cells Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma.
Human and Animal Cells Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P.
Human and Animal Cells By inhibiting Src, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells.
Human and Animal Cells The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway.